Report data readout from VERSATILE-002 phase 2 trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 31 Dec 2025
- Delivered
- 25 Aug 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Data readout from VERSATILE-002 (V-002)”
What we found
Evidence strength A What the grades mean
PDS Biotech announced final topline survival data readout from VERSATILE-002 Phase 2 trial on August 25, 2025, well before the Q4 2025 deadline.
-
A PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer Official SEC exhibit press release announcing final topline survival data
-
B PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer GlobeNewswire release confirming final topline survival data readout
-
C PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer - BioSpace Third-party news coverage confirming the data readout details
Checked 16 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you PDS Biotechnology Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-PDSB-000232 · Corrections policy